Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H. H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., Manry, J., Shaw, E., Haljasmägi, L., Peterson, P. [---] Goldbach-Mansky, R., Kisand, K., Lionakis, M. S., Puel, A., Zhang, S. Y., Holland, S. M., Gorochov, G., Jouanguy, E., Rice, C. M., Cobat, A., Notarangelo, L. D., Abel, L., Su, H. C., Casanova, J. L. 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science, 370(6515), eabd4585.
https://doi.org/10.1126/science.abd4585
Bastard, P., Gervais, A. [---] Peterson, P., Mogensen, T. H., Rowen, L., Mond, J., Debette, S., de Lamballerie, X., Duval, X., Mentré, F., Zins, M., Soler-Palacin, P., Colobran, R., Gorochov, G., Solanich, X., Susen, S., Marti nez-Picado, J., Raoult, D., Vasse, M., Gregersen, P. K., Piemonti, L., Rodríguez- Gallego, C., Notarangelo, L. D., Su, H. C., Kisand, K., Okada, S., Puel, A., Jouanguy, E., Rice, C. M., Tiberghien, P., Zhang, Q., Cobat, A., Abel, L., Casa nova, J. L. 2021a. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6(62), eabl4340.
https://doi.org/10.1126/sciimmunol.abl4340
Bastard P., Orlova, E., Sozaeva, L., Lévy, R., James, A., Schmitt, M. M., Ochoa, S., Kareva, M., Rodina, Y., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Neehus, A. L., Shaw, E., Migaud, M., Bizien, L., Ekwall, O., Berg, S., Beccuti, G., Ghizzoni, L., Thiriez, G., Pavot, A., Goujard, C., Frémond, M. L., Carter, E., Rothenbuhler, A., Linglart, A., Mignot, B., Comte, A., Cheikh, N., Hermine, O., Breivik, L., Husebye, E. S., Humbert, S., Rohrlich, P., Coaquette, A., Vuoto, F., Faure, K., Mahlaoui, N., Kotnik, P., Battelino, T., Trebušak Podkrajšek, K., Kisand, K., Ferré, E. M. N., DiMaggio, T., Rosen, L. B., Burbelo, P. D., McIntyre, M., Kann, N. Y., Shcherbina, A., Pavlova, M., Kolodkina, A., Holland, S. M., Zhang, S. Y., Crow, Y. J., Notarangelo, L. D., Su, H. C., Abel, L., Ander son, M. S., Jouanguy, E., Neven, B., Puel, A., Casanova, J. L., Lionakis, M. S. 2021b. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. Journal of Experimental Medicine, 218(7), e20210554.
https://doi.org/10.1084/jem.20210554
Bondet, V., Rodero, M. P., Posseme, C., Bost, P., Decalf, J., Haljasmägi, L., Bekaddour, N., Rice, G. I., Upasani, V., Herbeuval, J. P., Reynolds, J. A., Briggs, T.A., Bruce, I. N., Mauri, C., Isenberg, D., Menon, M., Hunt, D., Schwikowski, B., Mariette, X., Pol, S., Rozenberg, F., Cantaert, T., Gottenberg, J. E., Kisand, K., Duffy, D. 2021. Differential levels of IFNα subtypes in autoimmunity and viral infection. Cytokine, 144, 155533.
https://doi.org/10.1016/j.cyto.2021.155533
Cardoso, A. L., Fernandes, A., AguilarPimentel, J. A., de Angelis, M. H., Gue des, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., Schosserer, M., Grillari, J., Peterson, P., Tuna, B. G., Dogan, S., Meyer, A., van Os, R., Trendelenburg, A. U. 2018. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Research Reviews, 47, 214–277.
https://doi.org/10.1016/j.arr.2018.07.004
Haljasmägi, L., Remm, A., Rumm, A. P., Krassohhina, E., Sein, H., Tamm, A., Kisand, K., Peterson, P. 2020a. LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins. European Journal of Immunology, 50(8), 1234–1236.
https://doi.org/10.1002/eji.202048715
Haljasmägi, L., Salumets, A., Rumm, A. P., Jürgenson, M., Krassohhina, E., Remm, A., Sein, H., Kareinen, L., Vapalahti, O., Sironen, T., Peterson, H., Milani, L., Tamm, A., Hayday, A., Kisand, K., Peterson, P. 2020b. Longitudinal proteomic profiling reveals increased early inflammation and sustained apopto sis proteins in severe COVID-19. Scientific Reports, 10(1), 20533.
https://doi.org/10.1038/s41598-020-77525-w
Jõgi, P., Soeorg, H., Ingerainen, D., Soots, M., Lättekivi, F., Naaber, P., Toompere, K., Peterson, P., Haljasmägi, L., Žusinaite, E., Vaas, H., Pauskar, M., Shablinskaja, A., Kaarna, K., Paluste, H., Kisand, K., Oona, M., Janno, R., Lutsar, I. 2021. Prevalence of SARS-CoV-2 IgG antibodies and their associa tion with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study). Vaccine, 39(38), 5376–5384.
https://doi.org/10.1016/j.vaccine.2021.07.093
Kisand, K., Peterson, P. 2020. Metabolic fitness is decreased in monocytes of old individuals. Aging (Albany NY), 12(19), 18791–18792.
https://doi.org/10.18632/aging.104025
Laing, A. G., Lorenc, A., Del Molino Del Barrio, I., Das, A., Fish, M., Monin, L., Munoz- Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., Kamdar, S., Joseph, M., Davies, D., Davis, R., Jennings, A., Zlatareva, I., Vantourout, P., Wu, Y., Sofra, V., Cano, F., Greco, M., Theodoridis, E., Freedman, J. D., Gee, S., Chan, J. N. E., Ryan, S., Bugallo-Blanco, E., Peterson, P., Kisand, K., Haljas mägi, L., Chadli, L., Moingeon, P., Martinez, L., Merrick, B., Bisnauthsing, K., Brooks, K., Ibrahim, M. A. A., Mason, J., Lopez Gomez, F., Babalola, K., Abdul- Jawad, S., Cason, J., Mant, C., Seow, J., Graham, C., Doores, K. J., Di Rosa, F., Edgeworth, J., Shankar-Hari, M., Hayday, A. C. 2020. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nature Medicine, 26(10), 1623–1635.
https://doi.org/10.1038/s41591-020-1038-6
Naaber, P., Hunt, K., Pesukova, J., Haljasmägi, L., Rumm, P., Peterson, P., Holole jenko, J., Eero, I., Jõgi, P., Toompere, K., Sepp, E. 2020. Evaluation of SARSCoV2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. PLoS One, 15(10), e0237548.
https://doi.org/10.1371/journal.pone.0237548
Naaber, P., Tserel, L., Kangro, K., Sepp, E., Jürjenson, V., Adamson, A., Haljasmägi, L., Rumm, A. P., Maruste, R., Kärner, J., Gerhold, J. M., Planken, A., Ustav, M., Kisand, K., Peterson, P. 2021. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. The Lancet Regional Health Europe, 10, 100208.
https://doi.org/10.1016/j.lanepe.2021.100208
Saare, M., Tserel, L., Haljasmägi, L., Taalberg, E., Peet, N., Eimre, M., Vetik, R., Kingo, K., Saks, K., Tamm, R., Milani, L., Kisand, K., Peterson, P. 2020. Monocy tes present age-related changes in phospholipid concentration and decreased energy metabolism. Aging Cell, 19(4), e13127.
https://doi.org/10.1111/acel.13127
Tserel, L., Jõgi, P., Naaber, P., Maslovskaja, J., Häling, A., Salumets, A., Žusinaite, E., Soeorg, H., Lättekivi, F., Ingerainen, D., Soots, M., Toompere, K., Kaarna, K., Kisand, K., Lutsar, I., Peterson, P. 2021. Longterm elevated inf lammatory protein levels in asymptomatic SARS-CoV-2 infected individuals. Frontiers in Immunology, 12, 709759.
https://doi.org/10.3389/fimmu.2021.709759
